HEALTHCARE RESOURCE UTILIZATION IN PATIENTS TREATED WITH EMPAGLIFLOZIN IN EAST ASIA: RESULTS FROM EMPRISE STUDY

被引：0
|
作者：
Sheu, Wayne [1 ]
Seino, Yutaka [1 ]
Tan, Elise [1 ]
Yabe, Daisuke [1 ]
Ha, Kyoung Hwa [1 ]
Chung, Wook-Jin [1 ]
Taneda, Yusuke [1 ]
Lei, Wei-Yu [1 ]
Ustyugova, Anastasia [1 ]
Klement, Riho [1 ]
Deruaz-Luyet, Anouk [1 ]
Kyaw, Moe [1 ]
Kim, Dae Jung [1 ]
机构：
[1] Boehringer Ingelheim Pharmaceut Inc, EMPRISE East Asia Study Grp, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1470 / 1470
页数：1
相关论文
共 50 条
  • [1] Healthcare resource utilization in patients treated with empagliflozin in East Asia
    Sheu, Wayne H-H
    Seino, Yutaka
    Tan, Elise Chia-Hui
    Yabe, Daisuke
    Ha, Kyoung Hwa
    Nangaku, Masaomi
    Chung, Wook-Jin
    Node, Koichi
    Yasui, Atsutaka
    Lei, Wei-Yu
    Lee, Sunwoo
    Ustyugova, Anastasia
    Klement, Riho
    Deruaz-Luyet, Anouk
    Kyaw, Moe H.
    Kim, Dae Jung
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (05) : 810 - 821
  • [2] Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
    Seino, Yutaka
    Kim, Dae Jung
    Yabe, Daisuke
    Tan, Elise Chia-Hui
    Chung, Wook-Jin
    Ha, Kyoung Hwa
    Nangaku, Masaomi
    Node, Koichi
    Klement, Riho
    Yasui, Atsutaka
    Lei, Wei-Yu
    Lee, Sunwoo
    Kyaw, Moe H.
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly G.
    Sheu, Wayne H-H
    ENDOCRINOLOGY DIABETES & METABOLISM, 2021, 4 (01)
  • [3] Reduced healthcare utilization in patients using Empagliflozin: An interim analysis from the Empagliflozin comparative effectiveness and safety (EMPRISE) study
    Najafzadeh, Mehdi
    Pawar, Ajinkya
    Deruaz-Luyet, Anouk
    Brodovicz, Kimberly G.
    Ustyugova, Anastasia
    Bessette, Lily G.
    Gautam, Nileesa
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 223 - 224
  • [4] Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
    Karasik, A.
    Lanzinger, S.
    Tan, E. Chia-Hui
    Yabe, D.
    JungKim, D.
    Sheu, W. H-H
    Melzer-Cohen, C.
    Holl, R. W.
    Ha, K.
    Nystrom, T.
    Niskanen, L.
    Jensen, M. Linnemann
    Kyaw, M. H.
    Nunez, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 229 - 230
  • [5] Effectiveness and Safety of Empagliflozin in Routine Care in Europe and East Asia: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
    Karasik, Avraham
    Lanzinger, Stefanie
    Tan, Elise C. H.
    Yabe, Daisuke
    Kim, Dae Jung
    Sheu, Wayne H-H
    Cohen, Cheli Melzer
    Holl, Reinhard W.
    Ha, Kyoung Hwa
    Nystrom, Thomas
    Niskanen, Leo K.
    Jensen, Majken Linnemann
    Kyaw, Moe H.
    Nunez, Julio
    DIABETES, 2021, 70
  • [6] REDUCED HEALTHCARE UTILIZATION IN PATIENTS USING EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY
    Najafzadeh, M.
    Pawar, A.
    Deruaz-Luyet, A.
    Brodovicz, K. G.
    Ustyugova, A.
    Bessette, L. G.
    Gautam, N.
    Schneeweiss, S.
    Patorno, E.
    VALUE IN HEALTH, 2019, 22 : S161 - S161
  • [7] Healthcare utilization and cost associated with empagliflozin in older adults with type 2 diabetes: Results from the EMPRISE study
    Htoo, Phyo Than T.
    Tesfaye, Helen
    Schneeweiss, Sebastian
    Wexler, Deborah
    Glynn, Robert J.
    Schmedt, Niklas
    Deruaz-Luyet, Anouk
    Koeneman, Lisette
    Paik, Julie M.
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 13 - 14
  • [8] Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study (vol 4, e00181, 2021)
    Yutaka, S.
    Dae, J. K.
    Daisuke, Y.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2023,
  • [9] CARDIOVASCULAR EFFECTIVENESS OF EMPAGLIFLOZIN COMPARED TO DPP4I IN ROUTINE CARE IN EAST ASIA: RESULTS FROM THE EMPRISE STUDY
    Kim, Dae Jung
    Sheu, Wayne H-H
    Chung, Wook-Jin
    Yabe, Daisuke
    Ha, Kyoung Hwa
    Tan, Elise Chia-Hui
    Taneda, Yusuke
    Lei, Vanessa
    Saarelainen, Laura
    Deruaz-Luyet, Anouk
    Kyaw, Moe H.
    Seino, Yutaka
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 542 - 542
  • [10] Effectiveness and safety of empagliflozin: final results from the EMPRISE study
    Htoo, Phyo T.
    Tesfaye, Helen
    Schneeweiss, Sebastian
    Wexler, Deborah J.
    Everett, Brendan M.
    Glynn, Robert J.
    Schmedt, Niklas
    Koeneman, Lisette
    Deruaz-Luyet, Anouk
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETOLOGIA, 2024, 67 (07) : 1328 - 1342
12345